Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome

Karine KhatchadourianEndocrinology Service and Research Center of the Centre Hospitalier Universitaire Sainte Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, CanadaHorm Res 70:300-8. 2008

Role for tissue-dependent methylation differences in the expression of FOXE1 in nontumoral thyroid glands

..This study examined relationships between MRI findings and clinical/hormonal phenotypes in children with GHD in the observational Genetics and Neuroendocrinology of Short Stature International Study, GeNeSIS...

..Identification of TPIT gene mutations as the principal molecular cause of neonatal IAD permits prenatal diagnosis for families at risk for the purpose of early glucocorticoid replacement therapy...

Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome

Karine KhatchadourianEndocrinology Service and Research Center of the Centre Hospitalier Universitaire Sainte Justine, Department of Pediatrics, University of Montreal, Montreal, Quebec, CanadaHorm Res 70:300-8. 2008

..To evaluate factors contributing to the decision to initiate treatment with growth hormone (GH) in patients with Turner syndrome (TS)...

Role for tissue-dependent methylation differences in the expression of FOXE1 in nontumoral thyroid glands